Effects of antenatal glucocorticoids on the developing brain

Area of Science:

• Perinatology
• Developmental Biology
• Pharmacology

Background:

• Glucocorticoids (GCs) are vital for fetal organ maturation, crucial for survival outside the womb.
• Preterm infants often have insufficient endogenous GCs, leading to developmental complications like intraventricular hemorrhage (IVH), respiratory distress syndrome (RDS), and necrotizing enterocolitis (NEC).
• Synthetic GCs (sGCs) are used antenatally to accelerate organ development and mitigate these risks.

Purpose of the Study:

• To review the clinical application of antenatal sGC therapy in managing preterm birth.
• To explore the placental metabolism of sGCs.
• To assess the impact of antenatal sGCs on the developing fetal brain.

Main Methods:

• Literature review of current clinical practices and research on antenatal sGC therapy.
• Analysis of studies focusing on placental transfer and metabolism of synthetic glucocorticoids.
• Examination of evidence regarding the neurodevelopmental effects of antenatal sGC exposure.

Main Results:

• Antenatal sGCs are clinically effective in preventing major preterm birth complications (IVH, RDS, NEC).
• sGCs undergo placental metabolism, influencing fetal exposure levels.
• While beneficial, sGCs may be associated with adverse developmental side effects, particularly on the brain.

Conclusions:

• Antenatal sGC therapy is a cornerstone in managing preterm birth, balancing benefits against potential risks.
• Understanding placental metabolism is key to optimizing sGC therapy.
• Further research is needed to fully elucidate and mitigate the neurodevelopmental side effects of antenatal sGCs.